VIPCYEN
RegisteredUS US · App #79281429 · Reg #6144440
Owned by
Glaxo Group LimitedApplication date
2020-02-19
Registration date
2020-09-08
Published date
2020-06-23
First use date
—
Renewal date
—
Expiry date
—
Kind of mark
Trademark
Mark feature
Word
NICE Classes
5Pharmaceuticals
Domestic Classes
Jurisdiction-specific classifications outside WIPO 1-45 (e.g. US old classes).
006018044046051052
Current owners
Applicants
- Glaxo Group Limited
Previous owners
- Glaxo Group Limited
- Glaxo Group Limited
Correspondence
- [Legal Brand Protection, GSK]
Activity Summary
Oppositions
0
P 0 · D 0
Assignments
1
Security: 0
Renewals
3
Prosecution events
15
Renewals & Maintenance
| Kind | Effective date | Status |
|---|---|---|
| Earliest Filing Date | 2025-09-08 | — |
| Latest Filing Date Without Additional Fee | 2026-09-08 | — |
| Latest Filing Date With Additional Fee | 2027-03-08 | — |
Assignments & Security Interests
| Date | Conveyance | Assignor → Assignee | Type |
|---|---|---|---|
| 2023-07-27 | CHANGE OF ADDRESS | GLAXO GROUP LIMITED → GLAXO GROUP LIMITED | Transfer |
Prosecution History
15 events| Date | Event |
|---|---|
| 2025-05-30 | NEW REPRESENTATIVE AT IB RECEIVED |
| 2023-07-30 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| 2020-12-05 | NOTIFICATION PROCESSED BY IB |
| 2020-11-03 | GENERIC MADRID TRANSACTION SENT TO IB |
| 2020-11-03 | GENERIC MADRID TRANSACTION CREATED |
| 2020-10-08 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
| 2020-09-08 | REGISTERED-PRINCIPAL REGISTER |
| 2020-06-23 | PUBLISHED FOR OPPOSITION |
| 2020-06-03 | NOTICE OF PUBLICATION |
| 2020-05-15 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2020-05-07 | ASSIGNED TO EXAMINER |
| 2020-03-31 | APPLICATION FILING RECEIPT MAILED |
| 2020-03-26 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 2020-03-25 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| 2020-03-19 | SN ASSIGNED FOR SECT 66A APPL FROM IB |